194 related articles for article (PubMed ID: 34963310)
1. Why Is Only Type 1 Electrocardiogram Diagnostic of Brugada Syndrome? Mechanistic Insights From Computer Modeling.
Zhang Z; Chen PS; Weiss JN; Qu Z
Circ Arrhythm Electrophysiol; 2022 Jan; 15(1):e010365. PubMed ID: 34963310
[TBL] [Abstract][Full Text] [Related]
2. The transient outward potassium current plays a key role in spiral wave breakup in ventricular tissue.
Landaw J; Yuan X; Chen PS; Qu Z
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H826-H837. PubMed ID: 33385322
[TBL] [Abstract][Full Text] [Related]
3. Phase 2 Re-Entry Without I
Zhang Z; Brugada P; Weiss JN; Qu Z
JACC Clin Electrophysiol; 2023 Dec; 9(12):2459-2474. PubMed ID: 37831035
[TBL] [Abstract][Full Text] [Related]
4. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.
Bébarová M; O'Hara T; Geelen JL; Jongbloed RJ; Timmermans C; Arens YH; Rodriguez LM; Rudy Y; Volders PG
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H48-58. PubMed ID: 18456723
[TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome.
Szél T; Koncz I; Antzelevitch C
Heart Rhythm; 2013 Nov; 10(11):1720-7. PubMed ID: 23911896
[TBL] [Abstract][Full Text] [Related]
6. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
[TBL] [Abstract][Full Text] [Related]
7. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
Minoura Y; Di Diego JM; Barajas-Martínez H; Zygmunt AC; Hu D; Sicouri S; Antzelevitch C
J Cardiovasc Electrophysiol; 2012 Apr; 23(4):423-32. PubMed ID: 22034916
[TBL] [Abstract][Full Text] [Related]
8. Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.
Minoura Y; Panama BK; Nesterenko VV; Betzenhauser M; Barajas-Martínez H; Hu D; Di Diego JM; Antzelevitch C
Heart Rhythm; 2013 Jul; 10(7):1054-62. PubMed ID: 23499631
[TBL] [Abstract][Full Text] [Related]
9. Simulation of Brugada syndrome using cellular and three-dimensional whole-heart modeling approaches.
Xia L; Zhang Y; Zhang H; Wei Q; Liu F; Crozier S
Physiol Meas; 2006 Nov; 27(11):1125-42. PubMed ID: 17028406
[TBL] [Abstract][Full Text] [Related]
10. ST-Elevation Magnitude Correlates With Right Ventricular Outflow Tract Conduction Delay in Type I Brugada ECG.
Leong KMW; Ng FS; Yao C; Roney C; Taraborrelli P; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Boon Lim P; Harding SE; Peters NS; Kanagaratnam P; Varnava AM
Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038102
[TBL] [Abstract][Full Text] [Related]
11. Effects of the diuretic agent indapamide on Na+, transient outward, and delayed rectifier currents in canine atrial myocytes.
Lu Y; Yue L; Wang Z; Nattel S
Circ Res; 1998 Jul; 83(2):158-66. PubMed ID: 9686755
[TBL] [Abstract][Full Text] [Related]
12. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K
J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328
[TBL] [Abstract][Full Text] [Related]
13. Basis for the Induction of Tissue-Level Phase-2 Reentry as a Repolarization Disorder in the Brugada Syndrome.
Bueno-Orovio A; Cherry EM; Evans SJ; Fenton FH
Biomed Res Int; 2015; 2015():197586. PubMed ID: 26583094
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal Characteristics of QRS Complexes Enable the Diagnosis of Brugada Syndrome Regardless of the Appearance of a Type 1 ECG.
Guillem MS; Climent AM; Millet J; Berne P; Ramos R; Brugada J; Brugada R
J Cardiovasc Electrophysiol; 2016 May; 27(5):563-70. PubMed ID: 26799774
[TBL] [Abstract][Full Text] [Related]
15. New electrocardiographic criteria to differentiate the Type-2 Brugada pattern from electrocardiogram of healthy athletes with r'-wave in leads V1/V2.
Serra G; Baranchuk A; Bayés-De-Luna A; Brugada J; Goldwasser D; Capulzini L; Arazo D; Boraita A; Heras ME; Garcia-Niebla J; Elosua R; Brugada R; Brugada P
Europace; 2014 Nov; 16(11):1639-45. PubMed ID: 24603955
[TBL] [Abstract][Full Text] [Related]
16. Dependence of phase-2 reentry and repolarization dispersion on epicardial and transmural ionic heterogeneity: a simulation study.
Maoz A; Christini DJ; Krogh-Madsen T
Europace; 2014 Mar; 16(3):458-65. PubMed ID: 24569901
[TBL] [Abstract][Full Text] [Related]
17. Transient Outward K
Choi BR; Li W; Terentyev D; Kabakov AY; Zhong M; Rees CM; Terentyeva R; Kim TY; Qu Z; Peng X; Karma A; Koren G
Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e005414. PubMed ID: 29769222
[TBL] [Abstract][Full Text] [Related]
18. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
Zhang ZS; Tranquillo J; Neplioueva V; Bursac N; Grant AO
Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H399-407. PubMed ID: 16877553
[TBL] [Abstract][Full Text] [Related]
19. A mathematical model of phase 2 reentry: role of L-type Ca current.
Miyoshi S; Mitamura H; Fujikura K; Fukuda Y; Tanimoto K; Hagiwara Y; Ita M; Ogawa S
Am J Physiol Heart Circ Physiol; 2003 Apr; 284(4):H1285-94. PubMed ID: 12531737
[TBL] [Abstract][Full Text] [Related]
20. Low risk for arrhythmic events in asymptomatic patients with drug-induced type 1 ECG. Do patients with drug-induced Brugada type ECG have poor prognosis? (Con).
Nishizaki M; Sakurada H; Yamawake N; Ueda-Tatsumoto A; Hiraoka M
Circ J; 2010 Nov; 74(11):2464-73. PubMed ID: 20962431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
